Company: PFSA
Filing Date: 2025-10-09
Form Type: S-1
Source: 0001213900-25-097860
Chunk: 378

Company: Profusa, Inc.
Filing Date: 2025-10-09
Form: S-1
Chunk 378
---
 2025, the Company reconvened the special meeting to approve an extension of time for the Company to consummate an initial
business combination from March 22, 2025 to June 22, 2025. The meeting was adjourned until March 21, 2025, at which the
stockholders approve the extension of the business combination period until June 22, 2025. As a condition of the extension, the Company
contributed $ to the Trust Account, for the entire extension period, on March 21, 2025. On July 1, 2025, the Company filed
the Amendment to extend the date by which the Company must consummate a business combination or, if it fails to do so, cease its operations
and redeem or repurchase % of the shares of the Company’s common stock issued in the Company’s initial public offering,
from June 22, 2025 to August 22, 2025. In connection with the special meeting of stockholders to approve the Business Combination,
stockholders of the Company redeemed shares of common stock for an aggregate amount of $.

F-92 NORTHVIEW ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Note 2 — Significant Accounting Policies(cont.) As of June 30, 2025, $ 1,274,549of the Trust assets were classified as noncurrent assets and $ 661,012of the Trust assets due to redeeming stockholders were classified as current assets. As a result of the Business Combination, the $ 661,012due to redeeming stockholders was paid at the Closing. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature, except for the warrant liabilities, convertible promissory note, and securities purchase agreement. Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the condensed consolidated financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of June 30, 2025